Serum Exosomal lncRNA AC007099.1 Regulates the Expression of Neuropeptide-Related FAP, as a Potential Biomarker for Hepatocarcinogenesis

Figure 1

Upregulation and characterization of FAP expression in tumors. (a) Characterization of FAP expression in pancytopenia. (b) Validation of FAP expression at the translational level by the HPA database (immunohistochemistry). (c) FAP copy number differences in TCGA-LIHC. (d–f) The correlation of survival time (OS) (d), progression-free survival (PFS) (e), and disease-specific survival (DSS) (f) with FAP expression was analyzed by Kaplan-Meier method for plotting survival curves, respectively. (g) Differences in FAP promoter methylation in normal and tumor groups of TCGA-LIHC. (h) cBioPortal-based demonstration of genomic alterations of FAP in TCGA-LIHC.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)